Literature DB >> 16177815

Gene therapy progress and prospects: in tissue engineering.

J Polak1, L Hench.   

Abstract

Tissue engineering (TE) has existed for several years as an area spanning many disciplines, including medicine and engineering. The use of stem cells as a biological basis for TE coupled with advances in materials science has opened up an entirely new chapter in medicine and holds the promise of major contributions to the repair, replacement and regeneration of damaged tissues and organs. In this article, we review the spectrum of stem cells and scaffolds being investigated for their potential applications in medicine.

Mesh：

Substances：

Year:  2005        PMID： 16177815     DOI： 10.1038/sj.gt.3302651

Source DB:  PubMed          Journal:  Gene Ther        ISSN： 0969-7128            Impact factor:   5.250


  6 in total

Review 1.  Animal models to study host-bacteria interactions involved in periodontitis.

Authors:  Dana T Graves; Jun Kang; Oelisoa Andriankaja; Keisuke Wada; Carlos Rossa
Journal:  Front Oral Biol       Date:  2011-11-11

Review 2.  [Regenerative medicine in head and neck reconstructive surgery].

Authors:  F Riedel; U R Goessler; J Stern-Straeter; K Riedel; K Hörmann
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

3.  Engineering retina from human retinal progenitors (cell lines).

Authors:  Kamla Dutt; Yang Cao
Journal:  Tissue Eng Part A       Date:  2009-06       Impact factor: 3.845

4.  Twenty-first century challenges for biomaterials.

Authors:  Larry L Hench; Ian Thompson
Journal:  J R Soc Interface       Date:  2010-05-19       Impact factor: 4.118

5.  Human mesenchymal stem cell proliferation and osteogenic differentiation during long-term ex vivo cultivation is not age dependent.

Authors:  Stefan Fickert; Ute Schröter-Bobsin; Anna-Friederike Gross; Ute Hempel; Claudia Wojciechowski; Claudia Rentsch; Denis Corbeil; Klaus Peter Günther
Journal:  J Bone Miner Metab       Date:  2010-09-02       Impact factor: 2.626

Review 6.  Exploiting Advanced Hydrogel Technologies to Address Key Challenges in Regenerative Medicine.

Authors:  Daniel A Foyt; Michael D A Norman; Tracy T L Yu; Eileen Gentleman
Journal:  Adv Healthc Mater       Date:  2018-01-09       Impact factor: 9.933
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.